Robert Michael Wenham, Marco L. Davila, Daniel Abate-Daga, Melissa McGettigan, Xuefeng Wang, Theresa A. Boyle, Pamela D. Garzone, Amit Kumar, Denise Dorman, Richard Koya, Jose Conejo-Garcia. "Phase 1 clinical trial of autologous T-cells genetically engineered with a chimeric receptor to target the follicle-stimulating hormone receptor (FSHR) in recurrent ovarian cancer (OVCA).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps2682